Low Dose Versus Aggressive Inhibition of the Renin-Angiotensin-Aldosterone (RAS) to Treat Microalbuminuria

NCT00907374 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Microalbuminuria

Interventions

DRUG: benazepril
DRUG: benazepril

Sponsor

Charles Drew University of Medicine and Science